Innoveren Scientific Inc (IVRN) - Product Pipeline Analysis, 2025 Update
Description
SummaryInnoveren Scientific Inc (Innoveren Scientific), formerly H-CYTE Inc, operates as a life science and biotech incubator company that develops next-generation cellular therapies and medical devices. The company's portfolio includes innovative products such as SkinDisc, an active cellular matrix for rapid wound healing, and BreatheEasy, a medical device for managing COPD and related respiratory diseases. Innoveren employs advanced technologies, including Platelet Rich Plasma (PRP) techniques, and focuses on enhancing patient outcomes for life-threatening diseases and chronic health conditions. Innoveren Scientific is headquartered in Cincinnati, Ohio, the US.This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Innoveren Scientific Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
26 Pages
- Innoveren Scientific Inc Company Overview
- Innoveren Scientific Inc Company Snapshot
- Innoveren Scientific Inc Pipeline Products and Ongoing Clinical Trials Overview
- Innoveren Scientific Inc – Pipeline Analysis Overview
- Innoveren Scientific Inc - Key Facts
- Innoveren Scientific Inc - Major Products and Services
- Innoveren Scientific Inc Pipeline Products by Development Stage
- Innoveren Scientific Inc Pipeline Products Overview
- BreathEasy
- BreathEasy Product Overview
- DenerveX System
- DenerveX System Product Overview
- SkinDisc Ultra
- SkinDisc Ultra Product Overview
- Innoveren Scientific Inc - Key Competitors
- Innoveren Scientific Inc - Key Employees
- Innoveren Scientific Inc - Locations And Subsidiaries
- Head Office
- Recent Developments
- Innoveren Scientific Inc, Recent Developments
- Apr 08, 2025: Innoveren Scientific Receives 510(K) Clearance For SkinDisc Lite
- Mar 06, 2024: Innoveren Scientific Announces 510(k) Submission for SkinDisc Lite
- Jun 29, 2021: H-CYTE announces publication of positive real-world data relating to the use of innovative treatment (PRP-PBMC) aimed at helping improve overall lung health
- Jul 12, 2019: Medovex announces name change to H-CYTE and new ticker symbol
- Jun 24, 2019: Medovex’s transition to H-CYTE underscores biotechnology focus
- Feb 04, 2019: Medovex Corporation announces name change and full rebranding to Blue Zone Health
- Jan 15, 2019: Medovex names Michael Yurkowsky and Raymond Monteleone as board directors
- Oct 09, 2018: Medovex Names William E. Horne Chief Executive Officer and Chairman of the Board
- Sep 25, 2018: Medovex receives ISO 13485:2016 certification
- Jul 02, 2018: Medovex’s DenerveX System Demonstrates Clinical Benefits in Patients Suffering from Low Back Facet Joint Pain
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Innoveren Scientific Inc Pipeline Products and Ongoing Clinical Trials Overview
- Innoveren Scientific Inc Pipeline Products by Equipment Type
- Innoveren Scientific Inc Pipeline Products by Indication
- Innoveren Scientific Inc, Key Facts
- Innoveren Scientific Inc, Major Products and Services
- Innoveren Scientific Inc Number of Pipeline Products by Development Stage
- Innoveren Scientific Inc Pipeline Products Summary by Development Stage
- BreathEasy - Product Status
- BreathEasy - Product Description
- DenerveX System - Product Status
- DenerveX System - Product Description
- SkinDisc Ultra - Product Status
- SkinDisc Ultra - Product Description
- Innoveren Scientific Inc, Key Employees
- Glossary
- List of Figures
- Innoveren Scientific Inc Pipeline Products by Equipment Type
- Innoveren Scientific Inc Pipeline Products by Development Stage
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
